KILLING CANCER CELLS IN VITRO IS NOT ENOUGH
Can you anticipate the interplay between host animal and characteristics of the tumor model itself in immuno-oncology studies?
Scientists at MI Bioresearch have run close to 1,000 preclinical immuno-oncology studies over the past five years, thoughtfully evaluating all aspects of study design.
Read our guide to learn about:
- Modeling immuno-oncology in mouse models
- Maximizing tumor placement for stromal-tumor interactions
- Selecting a tumor model to test a checkpoint inhibitor
- Plus more!